Oral Mucositis Drugs Market

Global Oral Mucositis Drugs Market Size, Share & Trends Analysis Report By Types (Mouth Wash, Pain Control Medication, And Others), By End User (Supermarket/ Hospital, Diagnostics Clinic, Retail Pharmacy, Retail Pharmacy, Others), Forecast (2021 – 2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2024206 | Category : Pharmaceuticals | Delivery Format: /

The global anti oral mucositis drug market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the market is the increasing amount of cancer diseases and treatments related to it this factor will lead to the growth of the market during the forecast period. Oral mucositis is a complication that happens after cancer treatment such as radiotherapy and chemotherapy. The chemotherapy affects the inner lining epithelial cells and destroys the gastrointestinal tract due to which mucosal cells are wide open and can catch the infection. Due to this factor, the demand for the drug will grow during the forecast period.

Along with that, the rising geriatric population having cancer is also increasing which will likely drive the market. Oral-mucositis is diagnosed with brutal oral pain and ulcers due to which there is a higher need for a quick and efficient way to cure the pain that is fueling the demand for these drugs. Recently, in 2020, US FDA granted permission for the fast track launch of SGX942 (Soligenix, Inc.) for patients suffering from oral mucositis in combination with neck and head cancer. In 2020, BMG pharma added Gelx for the treatment of the disease.  Some of the key players in the global oral mucositis drug market include Amang Pharmaceuticals, Cellceutix, Izun Pharma, Himalaya, Oragenics, Kinnear Pharmaceuticals, Shoreline Pharmaceutical, and many others.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered- 

o By Type

o By End-User 

  • Regions Covered 

o North America

o Europe

o Asia-Pacific

o Rest of the World

  • Competitive Landscape- Amang Pharmaceuticals, Cellceutix, Izun Pharma, Himalaya, Oragenics, Kinnear Pharmaceuticals, Shoreline Pharmaceutical, and many others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Anti-Oral Mucositis Drug Market by Segments

o By Type

  • Mouth Wash
  • Pain Control Medication
  • Other

o By End-User 

  • Hospital 
  • Diagnostics clinic
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Global Anti-Oral Mucositis Drug Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa

REQUEST FOR TABLE OF CONTENT